Anebulo Pharmaceuticals Inc (ANEB)
2.73
+0.10
(+3.80%)
USD |
NASDAQ |
Jun 28, 16:00
Anebulo Pharmaceuticals Total Assets (Quarterly): 5.996M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 5.996M |
| December 31, 2023 | 7.501M |
| September 30, 2023 | 9.048M |
| June 30, 2023 | 11.67M |
| March 31, 2023 | 14.43M |
| December 31, 2022 | 16.89M |
| September 30, 2022 | 19.82M |
| Date | Value |
|---|---|
| June 30, 2022 | 15.58M |
| March 31, 2022 | 17.25M |
| December 31, 2021 | 18.96M |
| September 30, 2021 | 20.50M |
| June 30, 2021 | 21.65M |
| March 31, 2021 | 4.292M |
| December 31, 2020 | 2.610M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.610M
Minimum
Dec 2020
21.65M
Maximum
Jun 2021
13.30M
Average
15.01M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.010M |
| Shareholders Equity (Quarterly) | 4.985M |